Autoregulation of Glomerular Filtration Rate in Patients with Diabetes

  • Per K. Christensen
  • Hans-Henrik Parving

Abstract

The close relationship between elevated blood pressure and diabetic nephropathy are documented both in Type 1 and Type 2 diabetic patients. Approximately 75–85% of diabetic patients with nephropathy are hypertensive [1–3].

Keywords

Filtration Angiotensin Prostaglandin Gall Proteinuria 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89–93, 1984PubMedCrossRefGoogle Scholar
  2. 2.
    Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T: Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496–501, 1983PubMedCrossRefGoogle Scholar
  3. 3.
    Tarnow L, Rossing P, Gall M-A, Nielsen FS, Parving H-H: Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care 17(11): 1247–1251, 1994PubMedCrossRefGoogle Scholar
  4. 4.
    Rossing P, Hommel E, Smidt UM, Parving H-H: Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 42:715–719, 1993PubMedCrossRefGoogle Scholar
  5. 5.
    Parving H-H, Smidt UM, Hommel E, Mathiesen ER, Rossing P, Nielsen FS, Gall M-A: Effective Antihypertensive Treatment Postpones Renal Insufficiency in Diabetic Nephropathy. Am J Kidney Dis 22:188–195, 1993Google Scholar
  6. 6.
    Parving H-H, Rossing P, Hommel E, Smidt UM: Angiotensin converting enzyme inhibition in diabetic nephropathy: ten years experience. Am J Kidney Dis 26:99–107, 1995PubMedCrossRefGoogle Scholar
  7. 7.
    Björck S, Mulec H, Johnsen SA, Nordén G, Aurell M: Renal protective effect of enalapril in diabetic nephropathy. Br Med J 304:339–343, 1992CrossRefGoogle Scholar
  8. 8.
    Breyer JA, Bain P, Evans JK, Nahman NS, Lewis E, Cooper ME, McGill JB, Berl T, The Collaborative Study Group: Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int 50:1651–1658, 1996PubMedCrossRefGoogle Scholar
  9. 9.
    Walker WG, Hermann J, Murphy RP, Russell RP: Prospective study of the impact of hypertension upon kidney function in diabetes mellitus. Nephron 55(suppl 1):21–26, 1990Google Scholar
  10. 10.
    Yokoyama H, Tomonaga O, Hirayama M, Ishii A, Takeda M, Babazono T, Ujihara U, Takahashi C, Omori Y: Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Diabetologia 40:405–411, 1997PubMedCrossRefGoogle Scholar
  11. 11.
    Peterson JC, Adler S, Burkart JM, Green T, Herbert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL: Blood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease study. Ann Intern Med 123:754–762, 1995PubMedCrossRefGoogle Scholar
  12. 12.
    Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294:1443–1447, 1987CrossRefGoogle Scholar
  13. 13.
    Lebovitz HE, Wiegmann TB, Cnaan A, Shahinfar S, Sica D, Broadstone V, Schwartz SL, Mengel MC, Segal R, Versaggi JA, Bolten WK: Renal protective effects of enalapril in hypertensive NIDDM: Role of baseline albuminuria. Kidney Int 45(suppl. 45):S150–S155, 1994Google Scholar
  14. 14.
    Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Pairing H-H:Increased glome-rular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney Int 47:1726–1731, 1995PubMedCrossRefGoogle Scholar
  15. 15.
    Hansen HP, Nielsen FS, Rossing P, Jacobsen P, Jensen BR, Parving H-H: Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney Int 52:S49–S53, 1997Google Scholar
  16. 16.
    Anderson S: Relevance of single nephron studies to human glomerular function. Kidney Int 45:384–389, 1994PubMedCrossRefGoogle Scholar
  17. 17.
    Maddox DA, Brenner BM: Glomerular ultrafiltration, in The Kidney, edited by Brenner BM, Philidelphia, Saunders, 1996, p. 286Google Scholar
  18. 18.
    Dustin P: Arteriolar hyalinosis. Int Rev Exp Pathol 1:73–138, 1962Google Scholar
  19. 19.
    Østerby R, Gall M-A, Schmitz A, Nielsen FS, Nyberg G, Parving H-H: Glomerular structure and function in proteinuric Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1064–1070, 1993PubMedCrossRefGoogle Scholar
  20. 20.
    Wang X, Aukland K, Iversen BM: Acute effects of angiotensin II receptor antagonist on autoregulation of zonal glomerular filtration rate in renovascular hypertensive rats. Kidney Blood Pressure Research 20:225–232, 1997PubMedCrossRefGoogle Scholar
  21. 21.
    Iversen BM, Kvam FI, Mørkrid L, Sekse I, Ofstad J: Effect of cyclooxygenase inhibition on renal blood flow autoregulation in SHR. Am J Physiol 32:F534–F539, 1992Google Scholar
  22. 22.
    Pelayo JC, Westcott JY: Impaired autoregulation of glomerular capillary hydrostatic pressure in the rat remnant nephron. J Clin Invest 88:101–105, 1991PubMedCrossRefGoogle Scholar
  23. 23.
    Iversen BM, Kvam FI, Matre K, Ofstad J: Resetting of renal blood autoregulation during acute blood pressure reduction in hypertensive rats. Am J Physiol 44:R343–R349, 1998Google Scholar
  24. 24.
    Dworkin LD, Brenner BM: The renal circulations, in The Kidney, edited by Brenner BM, Philadelphia, Saunders, 1996, p. 247Google Scholar
  25. 25.
    Lush DJ, Fray JCS: Steady-state autoregulation of renal blood flow: a myogenic model. Am J Physiol 247:R89–R99, 1984PubMedGoogle Scholar
  26. 26.
    Aukland K, Oeien AH: Renal autoregulation: models combining tubuloglomerular feedback and myogenic response. Am J Physiol 252:F768–F783, 1987PubMedGoogle Scholar
  27. 27.
    Hayashi K, Epstein M, Loutzenhiser R: Determinants of the renal actions of atrial natriuretic peptide (ANP): lack of effect of ANP on pressure-induced vasocontriction. Circ Res 67:1–10, 1990PubMedCrossRefGoogle Scholar
  28. 28.
    Hayashi K, Epstein M, Loutzenhiser R: Pressure-induced vasocontriction of renal microvessels in normotensive and hypertensive rats: studies in the isolated perfused hydronephrotic kidney. Circ Res 65:1475–1484, 1989PubMedCrossRefGoogle Scholar
  29. 29.
    Hayashi K, Epstein M, Loutzenhiser R, Forster H: Impaired myogenic responsiveness of the afferent arteriole in streptozotocin-induced diabetic rats: Role of eicosanoid derangements. J Am Soc Nephrol 2:1578–1586, 1992PubMedGoogle Scholar
  30. 30.
    Hill GS, Heptinstall RH: Steorid-induced hypertension in the rat. Am J Pathol 52:1–39, 1968PubMedGoogle Scholar
  31. 31.
    Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925–1930, 1986PubMedCrossRefGoogle Scholar
  32. 32.
    Iversen BM, Ofstad J: Loss of renal blood flow autoregulation in chronic glomeru-lonephritic rats. Am J Physiol 254:F284–F290, 1988PubMedGoogle Scholar
  33. 33.
    Riser BL, Cortes P, Zhao X, Bernstein J, Dumler F, Narins RG: Intraglomerular pressure and mesangial stretchning stimulate extracellular matrix formation in the rat. J Clin Invest 90:1932–1943, 1992PubMedCrossRefGoogle Scholar
  34. 34.
    Kollros PR, Bates SR, Mathews MB, Horwitz AL, Glagov S: Cyclic AMP inhibits increased collagen production by cyclically stretched smooth muscle cells. Lab Invest 56:410–417, 1987PubMedGoogle Scholar
  35. 35.
    Mauer SM: Structural-functional correlations of diabetic nephropathy. Kidney Int 45:612–622, 1994PubMedCrossRefGoogle Scholar
  36. 36.
    Griffin KA, Picken MM, Bidani AK: Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J Am Soc Nephrol 4:2023–2031, 1994PubMedGoogle Scholar
  37. 37.
    Bidani AK, Schwartz M, Lewis E: Renal autoregulation and vulnerability to hypertensive injury in remnant kidney. Am J Physiol 252:F1003–F1010, 1987PubMedGoogle Scholar
  38. 38.
    Christensen PK, Hommel E, Clausen P, Feldt-Rasmussen B, Parving H-H: Impaired autoregulation of the glomerular filtration rate in patients with nondiabetic nephropathies. Kidney Int 56:1517–1523, 1999PubMedCrossRefGoogle Scholar
  39. 39.
    Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72:375–380, 1982PubMedCrossRefGoogle Scholar
  40. 40.
    Hashimoto Y, Ideura Y, Yoshimura A, Koshikawa S: Autoregulation of renal blood flow in streptozocin-induced diabetic rats. Diabetes 38:1109–1113, 1989PubMedCrossRefGoogle Scholar
  41. 41.
    Tolins JP, Shultz PJ, Raij L, Brown DM, Mauer M: Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO. Am J Physiol 265:F866–F895, 1993Google Scholar
  42. 42.
    Parving H-H, Kastrup J, Smidt Urn, Andersen AR, Feldt-Rasmussen B, Christiansen JS: Impaired autoregulation of glomerular filtration rate in Type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 27:547–552, 1984PubMedCrossRefGoogle Scholar
  43. 43.
    Brod J, Horbach L, Just H, Rosenthal J, Nicolescu R: Acute effects of clonidine on central and peripheral haemodynamics and plasma renin activity. Eur J Clin Pharm 4:107–114, 1972CrossRefGoogle Scholar
  44. 44.
    Onesti G, Bock KD, Heimsoth V, Kim KE, Merguet P: Clonidine: a new antihypertensive agent. Am J Cardiol 28:74–83, 1971PubMedCrossRefGoogle Scholar
  45. 45.
    Onesti G, Schwartz AB, Kim KE, Pas-Martinez V, Swartz C: Antihypertensive effect of clonidine. Circ Res 28:53–69, 1971Google Scholar
  46. 46.
    Christensen PK, Hansen HP, Parving H-H: Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients. Kidney Int 52:1369–1374, 1997PubMedCrossRefGoogle Scholar
  47. 47.
    Griffin KA, Picken MM, Bidani AK: Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys. J Clin Invest 96:793–800, 1995PubMedCrossRefGoogle Scholar
  48. 48.
    Apperloo AJ, De Zeeuw D, De Jong PE: A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. Kidney Int 51:793–797, 1997PubMedCrossRefGoogle Scholar
  49. 49.
    Klahr S: The modification of diet in renal disease study. N Engl J Med 320:864–866, 1989PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Per K. Christensen
    • 1
  • Hans-Henrik Parving
    • 1
  1. 1.Steno Diabetes CenterGentofteDenmark

Personalised recommendations